Stock Screener App

Gratuito - Play StoreApp Store

Installare Installare

Dow:

Nasdaq:

S&P 500:

A

$174.873.47%-6.28

Dopo l'orario di chiusura: 171.27-3.60 -2.06%

Agilent Technologies Inc (A)

Date: O: H: L: C: Vol:

Precedente Chiudi:

$181.15

Aprire:

$180.98

Volume 24 ore:

2,756,258

Volume relativo:

1.30

Capitalizzazione di mercato:

$49.30B

Reddito:

$7.23B

Utile/perdita netta:

$1.41B

Rapporto P/E:

35.12

EPS:

$4.98

Flusso di cassa netto:

$1.09B

1W Prestazione:

+1.04%

1M Prestazione:

+1.49%

6M Prestazione:

+51.34%

1Y Prestazione:

+21.98%

Intervallo 1D:

$173.38$180.98

Intervallo di 1 settimana:

$173.38$182.99

Portata 52W:

$108.35$182.99

Profilo aziendale di Agilent Technologies Inc (A)

Nome

Agilent Technologies Inc

Settore

Industria

Diagnostics & Research

Telefono

(408) 345-8886

Indirizzo

5301 STEVENS CREEK BLVD, SANTA CLARA, CA, USA

Dipendente

18,100

X

Prossima data di guadagno

2026-11-23

Ultimi documenti SEC

Discussioni di A su X

Confronta A con TMO, DHR, NTRA, WAT

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
A Agilent Technologies Inc	$174.87	$49.30B	$7.23B	$1.41B	$1.09B	$4.98
TMO Thermo Fisher Scientific Inc	$697.00	$257.71B	$45.20B	$6.87B	$6.75B	$18.19
DHR Danaher Corp	$232.23	$163.25B	$24.78B	$3.68B	$5.29B	$5.17
NTRA Natera Inc	$414.30	$59.72B	$2.50B	-$226.32M	$71.51M	-$1.64
WAT Waters Corp	$462.72	$45.46B	$3.77B	$449.25M	$240.68M	$7.86

Agilent Technologies Inc Azioni (A) Upgrade e downgrade

Data	Azione	Analista	Modifica della valutazione
2026-10-26	Iniziato	Deutsche Bank	Buy
2026-09-09	Resumed	UBS	Neutral
2026-07-09	Resumed	Jefferies	Hold
2026-06-26	Resumed	Bernstein	Outperform
2026-06-11	Iniziato	Piper Sandler	Neutral
2026-05-28	Aggiornamento	BofA Securities	Neutral → Buy
2026-05-27	Iniziato	RBC Capital Mkts	Outperform
2026-01-20	Iniziato	HSBC Securities	Buy
2026-01-05	Aggiornamento	Evercore ISI	In-line → Outperform
2025-12-15	Aggiornamento	Barclays	Equal Weight → Overweight
2025-12-09	Iniziato	Goldman	Buy
2025-12-02	Iniziato	Morgan Stanley	Overweight
2025-10-08	Iniziato	Rothschild & Co Redburn	Buy
2025-10-08	Aggiornamento	UBS	Neutral → Buy
2025-02-10	Aggiornamento	Barclays	Underweight → Equal Weight
2024-08-28	Iniziato	Wells Fargo	Overweight
2024-07-10	Aggiornamento	Citigroup	Neutral → Buy
2024-06-27	Downgrade	Wolfe Research	Outperform → Peer Perform
2024-06-03	Resumed	Jefferies	Hold
2024-04-05	Aggiornamento	Stifel	Hold → Buy
2023-12-13	Iniziato	Wolfe Research	Outperform
2023-12-12	Downgrade	BofA Securities	Buy → Neutral
2023-11-17	Downgrade	UBS	Buy → Neutral
2023-09-28	Iniziato	Bernstein	Mkt Perform
2023-07-31	Downgrade	Evercore ISI	Outperform → In-line
2023-05-24	Reiterato	Barclays	Equal Weight
2023-05-24	Reiterato	BofA Securities	Buy
2023-05-24	Reiterato	Citigroup	Neutral
2023-05-24	Reiterato	Credit Suisse	Outperform
2023-05-24	Reiterato	Evercore ISI	Outperform
2023-05-24	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
2023-05-24	Reiterato	Robert W. Baird	Outperform
2023-05-24	Reiterato	SVB Securities	Outperform
2023-05-24	Reiterato	Stifel	Hold
2023-05-24	Reiterato	TD Cowen	Outperform
2023-05-24	Reiterato	Wells Fargo	Overweight
2023-05-11	Iniziato	Barclays	Equal Weight
2023-01-10	Aggiornamento	Wells Fargo	Equal Weight → Overweight
2022-08-25	Iniziato	Credit Suisse	Outperform
2022-07-20	Iniziato	UBS	Buy
2022-07-08	Downgrade	Citigroup	Buy → Neutral
2022-04-25	Downgrade	Wells Fargo	Overweight → Equal Weight
2022-02-23	Reiterato	BofA Securities	Buy
2022-02-23	Reiterato	Citigroup	Buy
2022-02-23	Reiterato	Cowen	Outperform
2022-02-23	Reiterato	Evercore ISI	Outperform
2022-02-23	Reiterato	Stifel	Hold
2022-02-23	Reiterato	Wells Fargo	Overweight
2021-11-23	Reiterato	BofA Securities	Buy
2021-11-23	Reiterato	Cowen	Outperform
2021-11-23	Reiterato	Stifel	Hold
2021-03-18	Aggiornamento	Citigroup	Neutral → Buy
2021-02-17	Aggiornamento	BofA Securities	Neutral → Buy
2020-12-02	Iniziato	Goldman	Buy
2020-11-25	Aggiornamento	UBS	Neutral → Buy
2020-11-17	Aggiornamento	Cleveland Research	Neutral → Buy
2020-11-10	Iniziato	KeyBanc Capital Markets	Overweight
2020-09-30	Iniziato	Atlantic Equities	Neutral
2020-08-19	Reiterato	BofA Securities	Neutral
2020-08-19	Reiterato	Citigroup	Neutral
2020-08-19	Reiterato	Jefferies	Buy
2020-08-19	Reiterato	Robert W. Baird	Outperform
2020-08-19	Reiterato	SVB Leerink	Outperform
2020-08-19	Reiterato	Stifel	Hold
2020-08-19	Reiterato	Wells Fargo	Overweight
2020-02-24	Downgrade	Needham	Buy → Hold
2020-01-08	Iniziato	Wells Fargo	Overweight
2020-01-07	Iniziato	Citigroup	Neutral
2019-11-26	Reiterato	Needham	Buy
2019-11-15	Iniziato	Stifel	Hold
2019-10-18	Downgrade	UBS	Buy → Neutral
2019-07-16	Downgrade	BofA/Merrill	Buy → Neutral
2019-07-15	Downgrade	Barclays	Overweight → Equal Weight

Agilent Technologies Inc Azioni (A) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Agilent Technologies Inc Azioni (A) insider trading

Dolsten MikaelSep 04 '26
Director
Transazione
Proposed Sale
Costo
$151.38
#Azioni
634
Valore ($)
95,972
#Azioni Totale
0
Dolsten MikaelMay 29 '26
Director
Transazione
Proposed Sale
Costo
$135.42
#Azioni
1,600
Valore ($)
216,672
#Azioni Totale
0
Dolsten MikaelMay 29 '26
Director
Transazione
Sale
Costo
$135.42
#Azioni
1,600
Valore ($)
216,672
#Azioni Totale
5,548
Dolsten MikaelDec 01 '25
Director
Transazione
Proposed Sale
Costo
$149.81
#Azioni
2,600
Valore ($)
389,510
#Azioni Totale
0
Dolsten MikaelDec 01 '25
Director
Transazione
Sale
Costo
$149.81
#Azioni
2,600
Valore ($)
389,511
#Azioni Totale
4,973
Gonsalves RodneyNov 26 '25
Officer
Transazione
Proposed Sale
Costo
$154.99
#Azioni
3,000
Valore ($)
464,956
#Azioni Totale
0
Gonsalves RodneyNov 26 '25
V.P., Corporate Controller
Transazione
Sale
Costo
$154.99
#Azioni
3,000
Valore ($)
464,956
#Azioni Totale
31,846
MCDONNELL PADRAIGNov 18 '25
President and CEO
Transazione
Sale
Costo
$143.24
#Azioni
911
Valore ($)
130,492
#Azioni Totale
32,058
MCDONNELL PADRAIGNov 18 '25
Officer
Transazione
Proposed Sale
Costo
$143.24
#Azioni
911
Valore ($)
130,492
#Azioni Totale
0
MCDONNELL PADRAIGNov 12 '25
President and CEO
Transazione
Option Exercise
Costo
$109.86
#Azioni
12,490
Valore ($)
1,372,151
#Azioni Totale
45,938

Commercio interno	Relazione	Data	Transazione	Costo	#Azioni	Valore ($)	#Azioni Totale
Dolsten Mikael	Director	Sep 04 '26	Proposed Sale	$151.38	634	95,972	0
Dolsten Mikael	Director	May 29 '26	Proposed Sale	$135.42	1,600	216,672	0
Dolsten Mikael	Director	May 29 '26	Sale	$135.42	1,600	216,672	5,548
Dolsten Mikael	Director	Dec 01 '25	Proposed Sale	$149.81	2,600	389,510	0
Dolsten Mikael	Director	Dec 01 '25	Sale	$149.81	2,600	389,511	4,973
Gonsalves Rodney	Officer	Nov 26 '25	Proposed Sale	$154.99	3,000	464,956	0
Gonsalves Rodney	V.P., Corporate Controller	Nov 26 '25	Sale	$154.99	3,000	464,956	31,846
MCDONNELL PADRAIG	President and CEO	Nov 18 '25	Sale	$143.24	911	130,492	32,058
MCDONNELL PADRAIG	Officer	Nov 18 '25	Proposed Sale	$143.24	911	130,492	0
MCDONNELL PADRAIG	President and CEO	Nov 12 '25	Option Exercise	$109.86	12,490	1,372,151	45,938

Agilent Technologies Inc Borsa (A) Ultime notizie

ALGN Q3 Earnings & Revenues Beat, '26 Sales View Down, Stock Falls - Zacks Investment Research

Thailand Next Generation Sequencing (NGS) Market Size, Share, Trends, and Forecast - 2026 to 2036 | Precision Medicine Drives 12.7% CAGR and a $305.21 Million Opportunity - GlobeNewswire Inc.

Agilent Technologies on Track for Record High Close -- Data Talk - Moomoo

LH Stock Rises on Q3 Earnings and Revenue Beat, '26 View Up - Zacks Investment Research

Evercore ISI Adjusts Price Target on Agilent Technologies to $172 From $178 - marketscreener.com

What to Expect From Agilent Technologies’ Next Quarterly Earnings Report - Yahoo Finance

What to Expect From Agilent Technologies’ Next Quarterly Earnings Report - inkl

Agilent Technologies, Inc. (A) - Milk Road

Agilent Technologies Inc. and University of Chicago Announce Launch of Center of Excellence for Energy Materials Research - marketscreener.com

Deutsche Bank initiated coverage on Agilent with a new price target - Quantisnow

Deutsche Bank Initiates Coverage on Agilent Technologies With Buy Rating, $190 Price Target - marketscreener.com

Proscia to Join Agilent in Deal Worth Up to $270 Million - MyChesCo

Agilent Technologies, Inc. Estimates – NYSE:A - TradingView

Agilent Technologies Inc. stock outperforms competitors despite losses on the day - MarketWatch

DGX Q3 Earnings & Revenues Beat, '26 View Raised, Stock Down in Pre-Market - Zacks Investment Research

Agilent Technologies Inc. stock outperforms competitors on strong trading day - MarketWatch

Agilent Technologies Inc. stock outperforms competitors on strong trading day - MarketWatch

JPMorgan lifts target for Agilent Technologies stock to USD 195 - ad-hoc-news.de

29 ETFs Add to Agilent Technologies (A) on Oct. 16 - Yahoo Finance

Proscia’s bet on Philly talent pays off in a $240M Agilent buyout - Technical.ly

Agilent Technologies Inc. stock underperforms Monday when compared to competitors - MarketWatch

$1000 Invested In Agilent Technologies 10 Years Ago Would Be Worth This Much Today - Benzinga

Philadelphia’s Proscia to Sell to Agilent for Up to $270M - MyChesCo

Agilent Technologies Inc. stock underperforms Friday when compared to competitors - MarketWatch

Agilent Technologies Inc. Financials | AGIL - Barron's

Agilent Technologies, Inc. (A) Stock Forecasts - Yahoo Finance

Proscia Acquired by Agilent in $270M Philadelphia Tech Deal - Hoodline

Agilent Technologies (NYSE:A): Re‑Accelerating After a Two‑Year Soft Patch Thanks to the Backbone of Regulated Labs - Stocks Down Under

Philly-based AI medical analysis start-up to be acquired for up to $270 million - Inquirer.com

Agilent to buy Proscia for $240M - MedTech Dive

Why Agilent Is Spending up to $270 Million on an AI Pathology Specialist - Benzinga

Agilent acquires Proscia in deal worth up to $270m - Yahoo Finance

Agilent to Acquire Proscia for Up to $270M to Build Scientific Intelligence Layer in Digital Pathology - HIT Consultant

Agilent to expand capabilities in China - China Daily

UBS Adjusts Agilent Technologies Price Target to $180 From $165 - Moomoo

Agilent to buy pathology software maker Proscia for $240 million - Reuters

UBS Adjusts Agilent Technologies Price Target to $180 From $165 - Yahoo Finance

Agilent Technologies to Acquire Proscia for Up to $270 Million to Expand AI-Powered Digital Pathology Business - citybiz

Agilent Technologies (A) Acquires Proscia to Expand Digital Path - GuruFocus

Agilent Technologies to Acquire Proscia in All-Cash Deal - marketscreener.com

Agilent Technologies to Acquire Proscia in All-Cash Deal - Yahoo Finance

Agilent to Acquire Proscia, Advancing AI-Enabled Digital Pathology and Scientific Intelligence - Business Wire

Agilent to Acquire Proscia, Advancing AI-Enabled Digital Pathology and Scientific Intelligence - Yahoo Finance

Agilent Technologies Inc. Research & Ratings | AGIL - Barron's

TD Cowen Adjusts Price Target on Agilent Technologies to $196 From $180 - www.marketscreener.com

Agilent Technologies Inc. Advanced Charts | AGIL - Barron's

TD Cowen Adjusts Price Target on Agilent Technologies to $196 From $180 - Yahoo Finance

CWC | Agilent Technologies Announces European High-Speed Digital Seminar Tour - Cambridge Wireless

Agilent Technologies, Inc.: Dividend historical data and projections - marketscreener.com

Is Agilent Technologies (A) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Simile a A

WAT$462.723.61%

IQV$267.332.81%

IDXX$551.214.30%

NTRA$414.304.98%

ILMN$235.9918.64%

MTD$1,674.812.55%